The 11th Executive Congress on Translational Medicine, Biotech Innovation & Clinical Strategy supports the responsible dissemination of high-value clinical insights, translational research perspectives, biotech innovation outcomes, and executive strategy discussions. Where available, selected participants may be invited to explore publication-related opportunities aligned with the congress scope.
Publication is optional, event-dependent, and always subject to scope fit, editorial review, ethics requirements, and applicable policies.
Publication opportunities at ECTMBICS 2027, where available, are designed to extend the value of selected executive discussions, invited thought leadership, translational medicine insights, clinical research perspectives, biotech innovation outcomes, and academically grounded contributions. Availability may vary by session, topic relevance, and editorial alignment.
Participation in the congress does not automatically include publication. Any publication-related opportunity remains subject to invitation, suitability, independent editorial review, ethics requirements, and the requirements of the relevant outlet or format.
Executive Congresses does not guarantee acceptance, indexing, journal metrics, peer-review outcomes, or specific publication timelines.
Depending on session type, contribution quality, editorial suitability, and event arrangements, the following formats may be considered.
Selected contributors may be invited to develop an extended manuscript based on their congress contribution, clinical strategy case study, keynote, translational medicine topic, or academically mature presentation.
Where event-specific arrangements exist, selected submissions may be considered for publication pathways connected to relevant partner or associated outlets.
Selected non-confidential insights may be distilled into executive summaries, healthcare innovation briefs, clinical strategy notes, or congress outcome resources intended for strategic dissemination.
Confirm whether publication-related opportunities are available for your participation type, topic, or session category.
Where applicable, invited contributors receive the relevant instructions, deadlines, formatting expectations, and policy requirements.
Manuscripts or summaries are reviewed for originality, relevance, ethics alignment, quality, clarity, and fit with the intended outlet.
The final outcome may include acceptance, revision, deferral, or decline depending on editorial and quality considerations.
All submitted content must be original and must not infringe copyright, intellectual property rights, confidentiality obligations, patient privacy, institutional permissions, or third-party rights.
Executive Congresses does not support plagiarism, duplicate submission, fabricated data, ghostwriting, misleading claims, unethical authorship practices, or inappropriate clinical and research reporting conduct.
Where relevant, contributors may be asked to disclose conflicts of interest, ethics approvals, data permissions, clinical approvals, consent-related documentation, or institutional clearance.
Because ECTMBICS 2027 includes executive, clinical, industry, and institution-facing participation, contributors should avoid including proprietary, confidential, restricted, commercially sensitive, or patient-identifiable information unless expressly cleared for disclosure.
Some executive-level discussions may be suitable only for non-attributable summaries or high-level synthesized outcomes, rather than formal publication.
Publication suitability is therefore assessed not only on quality, but also on disclosure appropriateness, clinical sensitivity, research integrity, and strategic relevance.
No. Publication is optional and, where available, applies only to appropriate and selected contributions.
No. Congress participation and publication consideration are separate processes. Publication-related opportunities remain subject to invitation, editorial suitability, ethics requirements, and review processes.
If any publication-related fee applies for a specific pathway, it will be communicated clearly before you proceed.
No. These matters depend on the relevant outlet, editorial process, publisher policies, and external policies, and may change over time.
Share your proposed participation category, organisation, and topic area, and our team will confirm whether any publication-related pathways are applicable for ECTMBICS 2027.